Your announcement, placed where researchers actually read. We distribute scientific press releases to 200+ specialized life science media outlets, editorial desks, and research-focused digital channels worldwide.
When a biotech company announces a breakthrough in CRISPR delivery or a diagnostics firm launches a novel lateral flow platform, generic PR wire services send that announcement to the same journalists who cover tech earnings and retail trends. The result is predictable: silence from the people who matter most.
Researchers do not read BusinessWire. They read journals, scan discipline-specific news aggregators, follow trade publication newsletters, and monitor the editorial feeds of societies they belong to. Reaching them requires a distribution network built specifically for the scientific and research ecosystem.
LabsReach maintains direct relationships with editors, reporters, and content managers at over 200 specialized scientific media outlets. When we distribute your press release, it does not disappear into an undifferentiated newswire. It arrives in the inbox of an editor who covers your exact domain, formatted for their editorial calendar, and positioned for maximum coverage potential.
Every channel in our distribution network has been curated for scientific relevance. No spray-and-pray. No vanity impressions.
Direct placement with editorial teams at publications like GEN, The Scientist, BioTechniques, and Drug Discovery News. These outlets are read daily by researchers who influence purchasing decisions in labs worldwide.
Targeted distribution to discipline-specific trade press covering genomics, proteomics, analytical chemistry, clinical diagnostics, and laboratory automation. Each outlet serves a defined research community with verified readership.
Coverage across digital-first science news platforms, research aggregators, and online communities where scientists discover new products and technologies. This includes platforms like ResearchGate News, Science Daily, and Phys.org.
Personalized pitches to editors and journalists who cover your exact vertical. Whether your announcement concerns molecular biology instrumentation or computational drug discovery, we route it to reporters with demonstrated interest and coverage history in your field.
Amplification across LinkedIn scientific communities, Twitter/X science circles, and discipline-specific forums. We ensure your news reaches the informal but influential networks where researchers share, discuss, and validate new products and findings.
Syndication through international science wire services that reach research institutions, university news offices, and academic libraries across North America, Europe, and Asia-Pacific. Ideal for announcements with global research implications.
Our process ensures your news is not just distributed, but strategically positioned for maximum editorial pickup and researcher visibility.
We work with your team to identify the scientific narrative that will resonate with editors and researchers. What makes this newsworthy to a lab director? We distill the angle that gets coverage, not just impressions.
From our database of 200+ outlets, we build a custom media list for your announcement. Each contact is hand-selected based on their beat coverage, recent articles, editorial calendar alignment, and audience relevance.
Your release is distributed through our direct editorial channels and simultaneously pitched to priority journalists with personalized context. No mass blasts. Each touchpoint is calibrated for the recipient.
We monitor pickups across all channels in real-time and deliver a comprehensive coverage report including reach metrics, publication authority scores, audience demographics, and recommendations for amplification.
The fundamental challenge of scientific press release distribution is audience specificity. A press release about a new mass spectrometry platform and a press release about a gene therapy clinical trial share almost nothing in common, except that both must reach highly specialized audiences who will immediately detect superficiality.
Generic PR wire services treat all press releases identically. They distribute to broad, undifferentiated lists and measure success by "potential impressions," a vanity metric that conflates a pharma executive seeing your release with a technology journalist in consumer electronics receiving it in a digest they never open.
LabsReach operates differently because we understand the research ecosystem from the inside. Our distribution network of 200+ specialized outlets spans every major life science discipline, from genomics and cell biology to clinical chemistry and laboratory automation. When we distribute a press release, it reaches the editors, journalists, and digital platforms that your target researchers actually engage with.
The result is not just coverage. It is the right coverage, in the right publications, read by the right researchers, at the moment when your announcement matters most.
Whether you are launching a product or publishing landmark results, we ensure your news reaches the researchers and decision-makers who need to see it.
New instruments, reagents, kits, and software platforms. We distribute launch announcements to the specific research communities most likely to adopt, ensuring first impressions are made in the right publications.
Phase readouts, interim analyses, and pivotal trial data. Distributed to biotech-focused media, clinical research outlets, and therapeutic-area-specific trade publications with the scientific rigor these announcements demand.
Series rounds, grants, and strategic investments. Positioned to reach both the scientific audience who validates your technology and the industry watchers who track the competitive landscape in your space.
Collaborations, licensing deals, and co-development agreements. Distributed to outlets covering both partner organizations' domains, maximizing visibility across overlapping research communities.
Poster presentations, oral abstracts, and keynote summaries. Timed to conference schedules and distributed to attendees, non-attendees following remotely, and journalists covering the event.
FDA clearances, CE marks, and EUA authorizations. Distributed to regulatory-focused media, clinical outlets, and the downstream research communities who will be impacted by newly available products and therapies.
Tell us about your upcoming announcement. We will assess your distribution needs, recommend the right channel mix, and provide a detailed coverage projection within 24 hours.
Or email us directly at hello@labsreach.com